E-pharmacy in India: how online medicine orders work
An e-pharmacy takes a prescription or order online, gets it checked by a registered pharmacist and delivers medicines to the door. Here is how the model earns, and where the law still bites.
The short answer
An e-pharmacy is an online channel for ordering medicines. A customer uploads a prescription, a registered pharmacist verifies it, a licensed premises dispenses the order and a logistics partner delivers it, sometimes with cold-chain care. The business earns on drug margins, delivery fees, brand commissions and diagnostics tie-ins, and must work within the Drugs and Cosmetics Act and prescription rules.
Key takeaways
- An e-pharmacy is a licensed pharmacy selling online, with a registered pharmacist verifying prescriptions before dispensing.
- Revenue stacks drug margins, delivery fees, brand commissions and diagnostics tie-ins, and the mix decides profitability.
- Marketplace and inventory models carry different licensing obligations under the Drugs and Cosmetics Act and its rules.
- Schedule H and H1 drugs need a valid prescription, so verification logs are both a compliance and an audit asset.
- Last-mile and cold-chain costs, not gross margin alone, decide whether an e-pharmacy order makes money.
An e-pharmacy is a business that sells medicines to customers over the internet rather than across a counter. In India, the order usually starts with a prescription upload or a search for a product, passes through a registered pharmacist's check, gets dispensed from a licensed premises and reaches the customer by courier or a rider. The important word is "dispensed": an e-pharmacy is a retail channel wrapped in software, not a new category of medicine.
That distinction matters because it decides how you read the business. A pharmacy chain is judged on store count, footfall and same-store growth. An e-pharmacy is judged on order volume, repeat rate, prescription capture, delivery cost per order and how much of the basket is high-margin non-medicine. Mixing the two up leads to bad comparisons.
How does an e-pharmacy order actually flow?
The flow is fairly standard across players, even when the app looks different.
- Order or prescription upload. The customer either uploads a doctor's prescription as a photo or PDF, or searches for an over-the-counter (OTC) product that does not need one.
- Pharmacist verification. A registered pharmacist reviews the prescription for validity — doctor details, patient name, drug, strength and dosage — and either clears the order or calls the customer for a correction. Schedule H and Schedule H1 drugs, which Indian rules restrict to prescription-only sale, cannot move without this step.
- Dispensing. The order is picked and packed at a licensed pharmacy or a licensed warehouse. Batch number, expiry and quantity are recorded.
- Cold-chain handling. Products that need a temperature range — insulin, some vaccines, certain biologics — are packed with temperature-controlled material and, in better operations, shipped with a data logger so the chain of custody can be shown.
- Delivery and confirmation. A courier or rider delivers the order, often with an OTP, and the invoice and prescription copy travel with it.
Each step is a cost centre. Pharmacist time, packaging, cold-chain material and last-mile delivery all sit between the customer's payment and the platform's gross margin.
How do e-pharmacies make money?
Revenue comes from a few stacked streams, and the mix decides whether the business is a retailer or a marketplace.
- Drug margin. The spread between what the platform pays for a medicine and what it charges. This is the classic retail margin, and it varies widely by product — generics, branded generics and OTC products behave differently.
- Delivery and convenience fees. A fee on small baskets or express delivery. It rarely covers the true last-mile cost on its own.
- Brand and platform commissions. In a marketplace model, the platform earns a commission from sellers rather than owning the stock. In an inventory model, it earns the trading margin instead.
- Diagnostics and wellness tie-ins. Lab test bookings, health check-up packages, supplements and personal care. These categories carry better margins than chronic medicines and pull customers back more often.
- Subscription and loyalty. A paid membership that bundles free delivery and discounts, used to lock in repeat chronic-care customers.
Chronic-care baskets — diabetes, cardiac, thyroid — are the prize because they repeat every month. But they are also the most price-sensitive, which is why platforms push diagnostics and supplements to lift the overall margin.
Marketplace or inventory: why does the licensing model matter?
This is the question most readers skip and later regret. Under the Drugs and Cosmetics Act, 1940, and the rules made under it, the sale of drugs requires a licence for the premises where the sale happens. A marketplace that only connects buyers to licensed sellers has a different compliance posture from a platform that buys stock, holds it and sells it on its own account.
In practice, an inventory-led e-pharmacy needs licences for each warehouse or pharmacy it dispenses from, plus a registered pharmacist on duty. A marketplace needs to verify that every seller on it holds a valid licence and is selling only what it is permitted to sell. The distinction shapes everything downstream: who owns expiry risk, who handles returns of medicines, who is liable when a wrong drug is dispensed, and how the platform's take rate is calculated.
Prescription mandates sit on top of this. Under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, Schedule H drugs must be sold against a prescription from a registered medical practitioner, and Schedule H1 drugs carry stricter record-keeping. A model that allows a customer to tick a box to "upload later" would sit at the edge of that rule.
What should a founder or investor check before backing an e-pharmacy?
Treat the pitch deck like a compliance file as much as a P&L. A practical checklist:
- Licence map. Which entity holds which drug licence, for which premises, and does it cover every state the platform delivers into?
- Pharmacist ratio. How many registered pharmacists per shift, and how verification is logged and auditable.
- Prescription rejection rate. A very low rejection rate can signal weak checks; a very high one signals a broken funnel. Ask for the actual numbers.
- Cold-chain evidence. Temperature logs, packaging standards and what happens when a shipment is delayed.
- Margin mix. How much of gross margin comes from medicines versus diagnostics, supplements and fees.
- Regulatory history. Any show-cause notices, state drug controller actions or licence suspensions.
Regulatory risk in this sector is real. As adjacent context, a recent social media post attributed to India's food regulator, FSSAI, said the agency had taken action against six nutraceutical manufacturers over alleged violations including poor hygiene, missing records and use of expired or unapproved ingredients. The post named companies including Airen Herbals and Aquabliss Lifesciences. That action, as described, concerns nutraceutical manufacturers rather than e-pharmacy platforms, and the account rests on a social media post attributed to FSSAI rather than a confirmed FSSAI release, so it should be treated as unverified. For any platform that sells supplements alongside medicines, supplier verification is a live risk, not paperwork.
What it means for Indian retailers
For a traditional chemist, an e-pharmacy is a competitor on convenience and a possible partner on delivery. Many licensed retailers list on marketplaces precisely because it brings orders without building an app. For a founder, the model is a logistics and compliance business wearing a health-tech label. For an investor, the questions that matter are licence depth, pharmacist discipline, cold-chain proof and how much margin comes from anything other than medicines. Companies in Indian healthcare keep showing that regulatory developments can move value quickly; two recent examples, per company filings as reported in the media, are Biocon's EU approval for Pebrilzo and a DRI search at a Cipla depot, the latter being a pending matter rather than a resolution. In e-pharmacy, the equivalent trigger is a state drug controller's notice.
Common mistakes to avoid
- Assuming an app is a pharmacy. The licence sits with premises and people, not software.
- Treating OTC and prescription products as one catalogue with one margin.
- Underestimating returns and expiry on medicines, which cannot be resold like apparel.
- Building diagnostics as an afterthought rather than a margin engine with its own partners.
- Comparing an e-pharmacy's growth to a pharmacy chain's store-level sales without adjusting for basket size and delivery cost.
In this story
Frequently asked questions
Is an e-pharmacy legal in India?
E-pharmacies operate as licensed pharmacies selling online. Sale of drugs requires a licence under the Drugs and Cosmetics Act, 1940, and rules made under it, and prescription drugs need a valid prescription. The model sits within that framework rather than outside it, and state drug controllers enforce it.
How does an e-pharmacy verify a prescription?
The customer uploads a photo or PDF of the prescription. A registered pharmacist checks doctor details, patient name, drug, strength and dosage, then clears or queries the order. For Schedule H and H1 drugs, this step is mandatory before dispensing.
What is the difference between a marketplace and an inventory e-pharmacy?
A marketplace connects buyers to licensed sellers and earns commission, verifying each seller's licence. An inventory model buys and holds stock, dispenses from its own licensed premises and earns the trading margin, while carrying expiry and returns risk.
How do e-pharmacies handle cold-chain medicines?
Temperature-sensitive products such as insulin are packed with temperature-controlled material and, in better operations, shipped with data loggers so the temperature record can be shown. Delays and returns are the weak points to check.
Where does an e-pharmacy make its margin?
Mostly on drug margins and delivery fees, with diagnostics bookings, supplements and loyalty subscriptions adding higher-margin revenue. Chronic-care baskets repeat monthly but are price-sensitive, so platforms push non-medicine categories to lift overall margin.
